Manufacturer of sensor systems for security and defense purposes, Implant Sciences has announced that the US Department of Homeland Security has provided the recently launched narcotics and explosives trace detector, the Quantum Sniffer QS-B220 with the Developmental Testing & Evaluation (DT&E) Standard.
QS-B220
The bench-top narcotics and explosives trace detector instantaneously identifies the presence of trace quantities of various improvised, homemade, commercial or military grade narcotics or explosives by using ion mobility spectrometry.
The Chief Executive Officer of Implant Sciences, Glenn D Bolduc stated that the QS-B220 has been developed to serve as a vital tool in situations that require multi-layered security, such as in US points of entry like the airports. Bolduc further added that receiving the anti-terrorism DT&E designation for the trace detector marks an important milestone for Implant Sciences.
Brought into effect by the Homeland Security Act of 2002, the Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) facilitates the deployment and development of highly efficient anti-terrorism technologies.
The Quantum Sniffer QS-B220 contains no radioactive material and offers a low cost of ownership.
The portable explosives detector, QS-H150 has received the designation of a Qualified Anti-Terrorism Technology by the US Department of Homeland Security under the SAFETY Act.